Two Sigma Investments’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-160,385
| Closed | -$964K | – | 3293 |
|
|
2022
Q4 | $964K | Sell |
160,385
-35,364
| -18% | -$213K | ﹤0.01% | 1657 |
|
|
2022
Q3 | $1.14M | Sell |
195,749
-1,203,623
| -86% | -$7M | ﹤0.01% | 1359 |
|
|
2022
Q2 | $8.35M | Sell |
1,399,372
-419,590
| -23% | -$2.5M | 0.03% | 551 |
|
|
2022
Q1 | $8.5M | Buy |
1,818,962
+1,464,744
| +414% | +$6.84M | 0.03% | 655 |
|
|
2021
Q4 | $878K | Sell |
354,218
-715,025
| -67% | -$1.77M | ﹤0.01% | 1717 |
|
|
2021
Q3 | $3.15M | Sell |
1,069,243
-202,576
| -16% | -$598K | 0.01% | 1125 |
|
|
2021
Q2 | $3.18M | Buy |
1,271,819
+572,907
| +82% | +$1.43M | 0.01% | 1110 |
|
|
2021
Q1 | $2.03M | Buy |
698,912
+283,758
| +68% | +$826K | 0.01% | 1261 |
|
|
2020
Q4 | $1.34M | Buy |
415,154
+239,474
| +136% | +$771K | ﹤0.01% | 1236 |
|
|
2020
Q3 | $378K | Buy |
175,680
+138,188
| +369% | +$297K | ﹤0.01% | 1506 |
|
|
2020
Q2 | $43K | Sell |
37,492
-1,600
| -4% | -$1.84K | ﹤0.01% | 1907 |
|
|
2020
Q1 | $36K | Sell |
39,092
-30,861
| -44% | -$28.4K | ﹤0.01% | 1803 |
|
|
2019
Q4 | $111K | Sell |
69,953
-37,503
| -35% | -$59.5K | ﹤0.01% | 2046 |
|
|
2019
Q3 | $90K | Sell |
107,456
-22,356
| -17% | -$18.7K | ﹤0.01% | 1837 |
|
|
2019
Q2 | $112K | Sell |
129,812
-45,302
| -26% | -$39.1K | ﹤0.01% | 1929 |
|
|
2019
Q1 | $170K | Sell |
175,114
-44,455
| -20% | -$43.2K | ﹤0.01% | 1954 |
|
|
2018
Q4 | $161K | Buy |
219,569
+10,759
| +5% | +$7.89K | ﹤0.01% | 1903 |
|
|
2018
Q3 | $451K | Buy |
208,810
+56,841
| +37% | +$123K | ﹤0.01% | 1629 |
|
|
2018
Q2 | $757K | Buy |
151,969
+71,700
| +89% | +$357K | ﹤0.01% | 1481 |
|
|
2018
Q1 | $313K | Buy |
+80,269
| New | +$313K | ﹤0.01% | 1724 |
|
|
2014
Q2 | – | Sell |
-9,741
| Closed | -$331K | – | 2561 |
|
|
2014
Q1 | $331K | Buy |
9,741
+3,526
| +57% | +$120K | ﹤0.01% | 1634 |
|
|
2013
Q4 | $120K | Buy |
+6,215
| New | +$120K | ﹤0.01% | 2073 |
|